AMAidan T. Morrell

Aidan T. Morrell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aidan T. Morrell has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Gregory J. Golladay

    Department of Orthopaedic Surgery, Virginia Commonwealth University, Richmond, VA, USA

    3 shared publications
  • Stephen L. Kates

    Department of Orthopaedic Surgery, Virginia Commonwealth University, Richmond, VA, USA

    3 shared publications
  • Daniel R. Layon

    Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri

    2 shared publications
  • Nirav K. Patel

    Department of Orthopaedic Surgery, Virginia Commonwealth University, Richmond, VA, USA

    2 shared publications
  • Avital Y O’gLasser

    Hospital Medicine, Oregon Health & Science University, Portland, Oregon, USA

    1 shared publication
  • Cole McCallister

    Orthopaedics, Oregon Health & Science University, Portland, Oregon, USA

    1 shared publication

Latest Publications

  • Open Access

    Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study

    by Aidan Morrell, Steven Shelofsky, Hannah Hoffman, Cole McCallister, Thomas W Huff, Kathryn L Schabel, Avital Y O’gLasser, Ryland P Kagan

    Introduction: Patients with poor perioperative glycaemic control after total joint arthroplasty are at an increased risk of complications, mortality, delayed return to function and increased costs of care. Although correction of hyperglycaemia has been shown to improve patient outcomes, there is a lack of consensus regarding optimal perioperative glucose management after total joint replacement surgery. This pilot study aims to assess the feasibility of performing a multicentre randomised controlled trial to investigate the effect of perioperative metformin use on glycaemic control in the setting of total joint arthroplasty. Methods and analysis: This blinded, placebo-controlled, pilot randomised controlled trial will enrol 40 participants aged 18–99 years undergoing total hip or knee arthroplasty at a single academic tertiary centre. Patients will be randomly allocated to two groups of 20 participants each and will receive metformin or a placebo, respectively, for 2 weeks preoperatively, continued on the day of surgery, and up to 2 days postoperatively. The primary outcome is a composite of four endpoints to assess study feasibility: timely recruitment, timely study drug administration, protocol adherence and retention. Secondary outcomes include perioperative glycaemic variability, sliding scale insulin utilisation, hospital length of stay and 90-day rates of infection, mortality and readmission. Analyses will be on an intention-to-treat basis. Ethics and dissemination: The protocol was approved by Oregon Health & Science University Institutional Review Board, STUDY00025798. Written informed consent will be obtained for study participation. Findings will be disseminated via publication in peer-reviewed journals and conference presentations. Trial registration number: NCT06280274.


  • When Is a Clay-Shoveler's Fracture, Not a Clay-Shoveler's Fracture?

    by Matthew J. Schultz, Michael R. Wheeler, Loren O. Black, Aidan T. Morrell, Travis C. Philipp

    Case: A 71-year-old man with a history of C5-7 anterior cervical discectomy and fusion (ACDF) sustained a C7 spinous process fracture after falling from a ladder. He was initially managed nonoperatively but developed anterolisthesis and kyphosis at C7-T1 with left hand weakness over the course of 11 days. Surgical treatment included spinous process wiring and C5-T3 posterior fusion. At 14-month follow-up, he demonstrated resolution of pain and returned motor function. Conclusion: The patient's ACDF likely created a longer lever arm, allowing the force of his fall to be concentrated at C7-T1. Patients with a suspected Clay-Shoveler's fracture require close follow-up.

  • Top Cited Papers

    Enhanced Recovery After Primary Total Hip and Knee Arthroplasty

    by Aidan T. Morrell, Daniel R. Layon, Michael J. Scott, Stephen L. Kates, Gregory J. Golladay, Nirav K. Patel

    Background: Enhanced Recovery After Surgery (ERAS) has become increasingly implemented to reduce costs, to increase efficiency, and to optimize patient outcomes after a surgical procedure. This study aimed to systematically review the effect of ERAS after primary elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) on hospital length of stay, total procedure-related morbidity, and readmission. Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and with guidance from the Cochrane Handbook for Systematic Reviews of Interventions. MEDLINE, Embase, and Cochrane databases were searched from inception (1946 for MEDLINE and 1974 for Embase; Cochrane is a composite of multiple databases and thus does not report a standard inception date) until January 15, 2020. Prospective nonrandomized cohort studies and randomized controlled trials comparing adult patients undergoing elective primary THA or TKA with ERAS or traditional protocols were included. Articles examining outpatient, nonelective, or revision surgical procedures were excluded. Two reviewers independently assessed the risk of bias and extracted data. The primary outcome was length of stay. The secondary outcomes included total procedure-related morbidity and readmission. Results: Of the 1,018 references identified (1,017 identified through an electronic search and 1 identified through a manual search), 9 individual studies met inclusion criteria. Data were reported from 7,789 participants, with 2,428 receiving ERAS and 5,361 receiving traditional care. Narrative synthesis was performed instead of meta-analysis, given the presence of moderate to high risk of bias, wide variation of ERAS interventions, and inconsistent methods for assessing and reporting outcomes among included studies. Adherence to ERAS protocols consistently reduced hospital length of stay. Few studies demonstrated reduced total procedure-related morbidity, and there was no significant effect on readmission rates. Conclusions: ERAS likely reduced the length of stay after primary elective THA and TKA, with a more pronounced effect in selected healthier patient populations. We found minimal to no impact on perioperative morbidity or readmission. The quality of existing evidence was limited because of study heterogeneity and a significant risk of bias. Further high-quality research is needed to definitively assess the impact of ERAS on total joint arthroplasty. Level of Evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Enhanced Recovery After Surgery: An Orthopedic Perspective

    by Aidan T. Morrell, Stephen L. Kates, Laura A. Lahaye, Daniel R. Layon, Nirav K. Patel, Michael J. Scott, Gregory J. Golladay


  • The flipped third fragment in femoral shaft fractures: A reason for open reduction?

    by Daniel Layon, Aidan T. Morrell, Christopher Lee


  • Open Access

    Does Adherence to Preoperative Surgical Selection Criteria Reduce the Rate of Prosthetic Joint Infection in Primary and Revision Total Knee Arthroplasties?

    by Daniel R. Layon, William L. Johns, Aidan T. Morrell, Robert Perera, Nirav K. Patel, Gregory J. Golladay, Stephen L. Kates